Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan

Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan

BackgroundThe therapeutic options of relapsed or refractory multiple myeloma (RRMM) remain a challenge. The MM-003 trial demonstrated that RRMM patients treated with pomalidomide and dexamethasone (Pom/Dex) have better progression-free survival (PFS) than those treated with high-dose dexamethasone a...

Full description

Bibliographic Details
Main Authors: Yu-Chin Hung, Jyh-Pyng Gau, Shang-Yi Huang, Bor-Sheng Ko, Chieh-Lin Jerry Teng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
multiple myeloma
pomalidomide
treatment response
refractory
relapse
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.695410/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.695410/full

Similar Items